60
Participants
Start Date
December 31, 2024
Primary Completion Date
May 31, 2025
Study Completion Date
May 31, 2025
Sugammadex
When T2 appeared, the sugammadex group was given 2mg/kg of sugammadex intravenously (adjusted body weight), the neostigmine group was given 0.04mg/kg of neostigmine + 0.02mg/kg of atropine intravenously (adjusted body weight).
Neostigmine
When T2 appeared, the neostigmine group was given 0.04mg/kg of neostigmine + 0.02mg/kg of atropine intravenously (adjusted body weight).
Shanxi Bethune Hospital
OTHER